Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-05

Clinical Trial Update: A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing AVANDAMET (rosiglitazone/metformin) to metformin alone to assess longer-term glycemic effects in adults with Type 2 diabetes; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avandamet (rosiglitazone/metformin)
  • metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-04-05